论文部分内容阅读
目的:探讨米索前列醇用于预防产后出血临床效果并与缩宫素进行比较。方法:选择2007年3月-2010年3月于我院产科进行正常分娩的150例产妇作为研究对象,所有患者均未出现高危妊娠症状、无难产因素。近期均未使用过前列腺素抑制剂等。按照预防产后出血治疗方法不同分为两组,为实验组和对照组。其中实验组为75例产妇,采用米索前列醇进行治疗;对照组为75例产妇,采用缩宫素进行治疗,两组进行对比。结果:对第三产程、产后2h出血量和产后出血医疗分析显示,实验组和对照组比较均存在统计学意义(P<0.05),研究显示实验组出现8例副反应患者,对照组没有副反应患者;实验组经简单对症处理后症状很快缓解。结论:米索前列醇用于预防产后出血效果明显,应加强推广。
Objective: To investigate the clinical effect of misoprostol in preventing postpartum hemorrhage and to compare with oxytocin. Methods: From March 2007 to March 2010, 150 cases of normal delivery in obstetrics and gynecology department of our hospital were selected as the research object. All the patients had no symptoms of high risk pregnancy and no dystocia factors. No recent prostaglandin inhibitors have been used. In accordance with the prevention of postpartum hemorrhage treatment is divided into two groups for the experimental group and control group. Among them, 75 maternal women in the experimental group were treated with misoprostol, and 75 maternal women in the control group were treated with oxytocin. The two groups were compared. Results: The medical analysis of the third stage of labor, 2h postpartum hemorrhage and postpartum hemorrhage showed that the experimental group and the control group were statistically significant (P <0.05), the study showed that 8 cases of side effects in the experimental group, the control group without deputy Response patients; experimental group by symptomatic treatment symptoms quickly relieved. Conclusion: Misoprostol is effective in preventing postpartum hemorrhage and should be further promoted.